Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis
Clinical trial NCT02831855 · COMPLETED
Trial details
- NCT number
- NCT02831855
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2018-11-19
- Enrollment
- 694
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.